Changes in Beneficial Ownership · 4
Personalis, Inc.
PSNLNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-11042026_041102.xml
Filing details
- Report period
- 2026-11-03
- Issuer
- Personalis, Inc.
- Issuer CIK
- 0001527753
- Trading symbol
- PSNL
Reporting owner 1
- Name
- Hall Christopher M
- Reporting owner CIK
- 0001449535
- Relationship
- Director · Officer
- Officer title
- Chief Executive Officer
- Address
- C/O PERSONALIS, INC., 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-03 | S · Form 4 | 29,112[F1] | D | 15.87[F2] | 199,415 | D |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Direct
Footnotes
- F1
- Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.↩ 1
- F2
- The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $15.80 to $15.95 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.↩ 1
Signature 1
- Signed
- /s/ Aaron Tachibana, Attorney-in-Fact
- Date
- 2026-11-04
Company context
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care throughout the patient journey. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).